GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer.
GBP6 is identified as a mitochondrial regulator linking metabolic fitness to innate immune evasion in cervical cancer and is enriched in high-risk tumors and correlates with poor clinical outcomes.